The World Health Day theme highlighted the need to prevent the disease in the developing world, and the fact that many groups play a part
With brand new data showing that the global population with diabetes has reached 422 million, the World Health Organization’s selection is diabetes as its theme for World Health Day is well-timed. The day will focus on the need to prevent type 2 diabetes, especially in developing nations.
Meanwhile, in Geneva, Switzerland, a presentation of findings of the ACCISS study focused on the lack of availability of insulin for type 1 patients (and some with type 2 disease), more than 90 years after Canadian researchers discovered this life-saving therapy for patients who cannot produce their own.
According to the WHO, the aims of World Health Day are to:
· Build awareness of the global increase in the diabetes burden and its impact, especially in low- and middle-income countries.
· Create specific and affordable tactics to fight diabetes, with a focus on prevention.
· Launch a global report on diabetes, covering the impact of both type 1 and type 2 disease.
· Promote the fact that diabetes is preventable: work with food and beverage manufacturers, employers, educators, civic groups, the media and individuals themselves to change behavior.
Availability of Insulin
Researchers at the University of Geneva have been spreading the message about the cost of insulin for some time. A panel discussion today highlighted the fact that cost is barrier for about half the 100 million people who need insulin each day.
David Beran, a researcher at the University of Geneva’s division of tropical and humanitarian medicine, said there are companies that could supply cheaper insulin than the “big three”—Novo Nordisk, Sanofi, and Eli Lilly—including companies in India and China, where rates of diabetes are exploding. But discussions need to happen to create new, lower-cost sources of insulin. No generic formulations are available globally, the according to the University of Geneva group.
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Upadacitinib Shows Promise for Hard-to-Treat Crohn Disease
April 23rd 2025Upadacitinib showed promising results in achieving clinical and endoscopic remission in people with moderate to severe Crohn disease, including those previously treated with advanced therapies, offering a potential second-line treatment option with a manageable safety profile.
Read More
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More